Apogee Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $34.34-$95.31 |
Market Cap | $6.2B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.33 |
News
See moreYahoo Finance • 17 hours ago
Why Apogee Slipped On Its Dupixent-Rivaling Eczema Results
Yahoo Finance • yesterday
Apogee Therapeutics Shares Surge Following $1.3 Billion Blackstone Financing Partnership (APOG)
Yahoo Finance • last month
Apogee Therapeutics Inc. (APGE): Primary Challenger to Established Blockbusters
Yahoo Finance • last month
Merck & Co Inc: A Significant Addition to Eaton Vance Worldwide Health Sciences Fund
About
CEO | Dr. Michael Thomas Henderson M.D. |
Address | Building 17, Waltham, MA, United States, 02453 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 261 |